| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. | Chief Financial Officer | Restricted Stock Units | 9,500 | 02 Mar 2026 | Direct | ||
| Actinium Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 31 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNSP | CNS Pharmaceuticals, Inc. | 02 Mar 2026 | 1 | $0 | 4 | Chief Financial Officer | 04 Mar 2026, 17:01 |
| CNSP | CNS Pharmaceuticals, Inc. | 02 Mar 2026 | 0 | $0 | 3 | Chief Financial Officer | 04 Mar 2026, 17:00 |
| ATNM | Actinium Pharmaceuticals, Inc. | 31 Mar 2025 | 9 | $0 | 4 | Chief Financial Officer | 02 Apr 2025, 18:20 |
| ATNM | Actinium Pharmaceuticals, Inc. | 28 Dec 2023 | 1 | $0 | 4 | Chief Financial Officer | 29 Dec 2023, 17:20 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Chief Financial Officer, Director | 01 Jul 2022, 19:19 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Sep 2021 | 1 | $0 | 4 | Chief Financial Officer | 03 Sep 2021, 17:02 |